Clinical Trial Update: To Evaluate the Efficacy and Safety of Micafungin in Preventing Invasive Mycosis After Liver Transplantation [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating micafungin for prevention of invasive fungal infections after liver transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplantation

Drugs mentioned

• Micafungin (micafungin)

Snippet

Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Liver Transplantation | Phase 4 | Status: UNKNOWN